MISSISSAUGA, Ont.—Baylis Medical Co. is launching a major expansion project at its manufacturing plant outside Toronto.
The company plans to invest $32.5 million toward building a new research and development facility it says will boost exports and allow it to reach new clients. Adding a $4.2 million investment from the province of Ontario to its own multi-million-dollar contribution, the medical device company says the new plant will double the number of controlled rooms and R&D spaces at its Mississauga, Ont plant.
“This new facility will give us the space to increase production and hire additional resources to expand our portfolio of innovative products,” the company’s president, Krishan Shah, said. “This strategic partnership will help us compete and succeed globally.”
A manufacturer of medical devices used in cardiology, radiology, and spinal procedures, Baylis plans to use the project to branch out to new markets such as Australia, Brazil, China and South Korea. The company says it expects to almost double its exports over the next seven years.
Ontario said the project is expected to create 84 jobs in Mississauga, as well as enhance research collaborations between the medical firm and a number of academic and research institutions in Ontario, including Sunnybrook Research Institute, the University of Toronto, London Health Sciences and Sick Kids Hospital.